Information
-
Trademark
-
87603889
-
Serial Number
87603889
-
Registration Number
5791315
-
International Classifications
-
Filing Date
September 11, 2017
7 years ago
-
Registration Date
July 02, 2019
5 years ago
-
Transaction Date
November 27, 2024
4 months ago
-
Status Date
July 02, 2019
5 years ago
-
Published for Opposition Date
April 16, 2019
5 years ago
-
Location Date
July 02, 2019
5 years ago
-
Status Code
700
-
Current Location
PUBLICATION AND ISSUE SECTION
Employee Name
GULIANO, ROBERT
-
Attorney Docket Number
STP20240322
Attorney Name
Hun Joon Kim
Law Office Assigned Location Code
L50
-
Owners
Mark Drawing Code
3
Mark Identification
KOBIOLABS
Case File Statements
- DM0000: The mark consists of the word "KOBIOLABS" in block lettering with the "KO" in the color yellow-green and the "BIOLABS" in the color gray. To the left of the word "KOBIOLABS" is a circular design shaded gray on the interior edges of the circle and transitioning to white towards the circle's interior. A green leaf is positioned in the center of the circle. The rest of the white represents background and is not part of the mark. All other white and gray in the mark represents background and shading areas and is not part of the mark.
- GS0051: Pharmaceutical and veterinary preparations, namely, preparations for the prevention of inflammatory bowel disease, irritable bowel syndrome, constipation, diarrhea, metabolic syndrome, obesity, diabetes, hypertension, insulin resistance, high blood cholesterol, high blood Triglycerides, cardiovascular disease, autoimmune disease, atopic dermatitis, arthritis, asthma, allergy, Crohn's disease, mental diseases, neurodegenerative disease, cancer, infectious disease, liver disease and inflammatory disease; Microorganism preparations, namely, nutritive substances for microorganisms for medical or veterinary purposes; Microorganism preparations, namely, microorganism cells for medical or veterinary purposes; Cultures of microorganisms for medical purposes; Biological preparations for medical or veterinary purposes, namely, preparations for the treatment of inflammatory bowel disease, irritable bowel syndrome, constipation, diarrhea, metabolic syndrome, obesity, diabetes, hypertension, insulin resistance, high blood cholesterol, high blood Triglycerides, cardiovascular disease, autoimmune disease, atopic dermatitis, arthritis, asthma, allergy, Crohn's disease, mental diseases, neurodegenerative disease, cancer, infectious disease, liver disease and inflammatory disease; Dietetic food supplements; Dietetic foods adapted for medical purposes; Nutraceuticals for medical purposes, namely, for the treatment of inflammatory bowel disease, irritable bowel syndrome, constipation, diarrhea, metabolic syndrome, obesity, diabetes, hypertension, insulin resistance, high blood cholesterol, high blood Triglycerides, cardiovascular disease, autoimmune disease, atopic dermatitis, arthritis, asthma, allergy, Crohn's disease, mental diseases, neurodegenerative disease, cancer, infectious disease, liver disease and inflammatory disease
- CC0000: The colors white, gray, green and yellow-green are claimed as a feature of the mark.
- GS0441: Performing diagnosis of diseases; Provision of genetic testing for medical treatment purposes; Provision of gene therapy for medical treatment purposes; DNA screening for medical purposes; Consultation and providing information in the fields of medicine and health
- GS0421: Consultation in the field of health risk assessment, namely, predicting health risks of individuals with regard to medical disease; Drug discovery services; Provision of scientific information and advice in the field of microorganisms; DNA testing for scientific research purposes; DNA analysis for scientific research purposes; DNA sequencing analysis for scientific research purposes; consultation and providing information in the fields of biomedicine for scientific and research purposes; Consultancy in analysis of biology sequence processing for medical research purposes; Consultancy in analysis of genomics for medical research purposes; scientific research in the fields of medicine, health and pharmacology; Consultation and providing information in the fields of and pharmacology
Case File Event Statements
-
12/14/2017 - 7 years ago
4 - ASSIGNED TO EXAMINER
Type: DOCK
-
9/14/2017 - 7 years ago
1 - NEW APPLICATION ENTERED
Type: NWAP
-
9/15/2017 - 7 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
9/16/2017 - 7 years ago
3 - NOTICE OF DESIGN SEARCH CODE E-MAILED
Type: MDSC
-
12/18/2017 - 7 years ago
5 - EXAMINERS AMENDMENT -WRITTEN
Type: CNEA
-
12/18/2017 - 7 years ago
6 - EXAMINERS AMENDMENT E-MAILED
Type: GNEA
-
12/18/2017 - 7 years ago
7 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Type: GNEN
-
12/18/2017 - 7 years ago
8 - EXAMINER'S AMENDMENT ENTERED
Type: XAEC
-
12/21/2017 - 7 years ago
9 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
12/21/2017 - 7 years ago
10 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
12/21/2017 - 7 years ago
11 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
6/8/2018 - 6 years ago
12 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
6/9/2018 - 6 years ago
14 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
6/8/2018 - 6 years ago
13 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
6/19/2018 - 6 years ago
15 - EXAMINERS AMENDMENT -WRITTEN
Type: CNEA
-
6/19/2018 - 6 years ago
16 - EXAMINERS AMENDMENT E-MAILED
Type: GNEA
-
6/19/2018 - 6 years ago
17 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Type: GNEN
-
6/19/2018 - 6 years ago
18 - EXAMINER'S AMENDMENT ENTERED
Type: XAEC
-
9/5/2018 - 6 years ago
19 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
9/5/2018 - 6 years ago
20 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
9/5/2018 - 6 years ago
21 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
2/25/2019 - 6 years ago
22 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
2/25/2019 - 6 years ago
23 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
2/26/2019 - 6 years ago
24 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
2/28/2019 - 6 years ago
25 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
4/16/2019 - 5 years ago
27 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
3/27/2019 - 6 years ago
26 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
4/16/2019 - 5 years ago
28 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
5/10/2019 - 5 years ago
29 - TEAS CHANGE OF CORRESPONDENCE RECEIVED
Type: TCCA
-
7/2/2019 - 5 years ago
30 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
11/27/2024 - 4 months ago
34 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Type: REAP
-
11/27/2024 - 4 months ago
37 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Type: ECDR
-
11/27/2024 - 4 months ago
38 - TEAS CHANGE OF CORRESPONDENCE RECEIVED
Type: TCCA
-
11/27/2024 - 4 months ago
32 - TEAS CHANGE OF OWNER ADDRESS RECEIVED
Type: COAR
-
11/27/2024 - 4 months ago
33 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Type: CHAN
-
11/27/2024 - 4 months ago
35 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Type: ARAA
-
11/27/2024 - 4 months ago
36 - TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Type: EWOR
-
7/2/2024 - 9 months ago
31 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Type: REM1